D
BioHarvest Sciences Inc. BHST
$5.32 $0.12912.49%
Recommendation
Sell
Prev Close
$5.19
Volume
12,848
Avg Vol (90D)
8,264
Market Cap
$89.98M
Dividend & Yield
--
52-Week Range
$0.0011 - $7.70
P/E (TTM)
--
EPS (TTM)
-$1.19
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
3/6/2025 - Newsfile Corp. - News Releases
BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound
3/4/2025 - Proactive Investors - UK
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
3/4/2025 - Newsfile Corp. - News Releases
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar
2/26/2025 - Simply Wall St
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion
2/18/2025 - Proactive Investors - UK
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
2/18/2025 - Newsfile Corp. - News Releases
BioHarvest Sciences to Delist from CSE, Focuses on Nasdaq
2/14/2025 - TipRanks Financial Blog
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
2/12/2025 - Newsfile Corp. - News Releases
BioHarvest Sciences Appoints Sharon Malka to Board of Directors
1/23/2025 - TipRanks Financial Blog
BioHarvest Sciences appoints veteran technology leader to board of directors
1/22/2025 - Proactive Investors - UK
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
1/22/2025 - Newsfile Corp. - News Releases
BioHarvest Sciences positioned for 'legacy year' in 2025, building on momentum with new innovations and strategic collaborations
1/20/2025 - Proactive Investors - UK
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth
1/8/2025 - Proactive Investors - UK
BioHarvest Issues Shareholder Letter and Provides Corporate Update
1/8/2025 - Newsfile Corp. - News Releases
Bioharvest Sciences (BHST, $6.17) entered Downtrend as Momentum indicator drops below 0 level on Jan 07, 2025
1/8/2025 - Tickeron - Stocks
Bioharvest Sciences (BHST, $6.12) entered Downtrend as Momentum indicator drops below 0 level on Jan 02, 2025
1/3/2025 - Tickeron - Stocks
Bioharvest Sciences (BHST, $5.91) price may climb as it broke lower Bollinger Band on Dec 30, 2024
12/31/2024 - Tickeron - Stocks
Bioharvest Sciences (BHST, $6.15) Aroon Indicator entered an Uptrend on December 27, 2024.
12/28/2024 - Tickeron - Stocks
Bioharvest Sciences (BHST, $6.1) Aroon Indicator entered an Uptrend on December 26, 2024.
12/27/2024 - Tickeron - Stocks
Bioharvest Sciences (BHST, $6.1) Aroon Indicator entered an Uptrend on December 24, 2024.
12/25/2024 - Tickeron - Stocks
Bioharvest Sciences (BHST, $6.2) Aroon Indicator entered an Uptrend on December 23, 2024.
12/24/2024 - Tickeron - Stocks
Bioharvest Sciences (BHST, $6.2) entered Downtrend as Momentum indicator drops below 0 level on Dec 23, 2024
12/24/2024 - Tickeron - Stocks
Bioharvest Sciences (BHST, $6.29) Aroon Indicator entered an Uptrend on December 20, 2024.
12/21/2024 - Tickeron - Stocks
BioHarvest Sciences (NASDAQ:BHST) Now Covered by Maxim Group
12/21/2024 - Ticker Report
Bioharvest Sciences (BHST, $6.2) Aroon Indicator entered an Uptrend on December 19, 2024.
12/20/2024 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
$22.43M
EBITDA (TTM)
-$6.84M
EBIT (TTM)
-$7.85M
Net Income (TTM)
-$17.19M
Balance Sheet
Total Assets (Q)
$25.82M
Total Debt (Q)
$10.70M
Total Liabilities (Q)
$21.68M
Book Value Per Share (Q)
$0.2389
Cash Flow
Cash from Operations (TTM)
-$7.29M
Cash from Investing (TTM)
-$2.92M
Cash from Financing (TTM)
$11.34M
Net Change in Cash (TTM)
$1.21M
Filings
Filing Date
Monday, November 25, 2024
Period Date
Monday, September 30, 2024
Next Filing
End of April (est)
Price History
Loading...
Beta
0.33
7-Day Total Return
-5.81%
30-Day Total Return
1.37%
60-Day Total Return
-12.02%
90-Day Total Return
10.18%
Year to Date Total Return
-13.03%
1-Year Total Return
-1.84%
2-Year Total Return
-12.89%
3-Year Total Return
-44.73%
5-Year Total Return
--
52-week Low
Jun 03, 2024 - $0.0011
52-week High
Mar 21, 2024 - $7.70
Valuation
Market Cap
$89.98M - Micro Cap
Enterprise Value
$97.91M
Price/Sales (TTM)
4.01
Price/Book (Q)
21.74
Dividends and Shares
Shares Outstanding
17.34M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bioharvest.com
Phone Number
(604) 622-1186
Address
1140-625 Howe Street
Vancouver, BC V6C 2T6
Country
Canada
Year Founded
--
Business Description
Sector
Consumer Staples
Industry
Household and Personal Products
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow... more
NASDAQ 03/07/2025 3:57PM Eastern Quotes delayed
Weiss Ratings